X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9731) 9731
Publication (660) 660
Book Review (116) 116
Newsletter (110) 110
Magazine Article (19) 19
Newspaper Article (17) 17
Book Chapter (15) 15
Conference Proceeding (8) 8
Dissertation (3) 3
Data Set (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8946) 8946
male (5559) 5559
female (5245) 5245
interferon-alpha - adverse effects (4913) 4913
middle aged (4881) 4881
adult (4283) 4283
interferon-alpha - therapeutic use (4109) 4109
index medicus (3335) 3335
recombinant proteins (3204) 3204
antiviral agents - adverse effects (2643) 2643
aged (2639) 2639
hepatitis c, chronic - drug therapy (2577) 2577
interferon-alpha - administration & dosage (2539) 2539
antiviral agents - therapeutic use (2490) 2490
treatment outcome (2483) 2483
interferon-alpha (2363) 2363
drug therapy, combination (2053) 2053
interferon (1772) 1772
oncology (1770) 1770
ribavirin - therapeutic use (1662) 1662
therapy (1644) 1644
gastroenterology & hepatology (1560) 1560
hepatitis c (1535) 1535
ribavirin - adverse effects (1478) 1478
ribavirin (1326) 1326
polyethylene glycols - therapeutic use (1239) 1239
polyethylene glycols - adverse effects (1184) 1184
antiviral agents - administration & dosage (1141) 1141
hepatitis c - drug therapy (1008) 1008
care and treatment (976) 976
hepacivirus - genetics (958) 958
ribavirin - administration & dosage (936) 936
interferon alpha (887) 887
virus-infection (884) 884
antineoplastic combined chemotherapy protocols - therapeutic use (847) 847
hepatitis c virus (837) 837
pharmacology & pharmacy (837) 837
antineoplastic agents - adverse effects (835) 835
cancer (826) 826
interferon alpha-2 (823) 823
antineoplastic agents - therapeutic use (804) 804
biological response modifiers (802) 802
genotype (800) 800
drug administration schedule (779) 779
drug therapy (778) 778
recombinant proteins - therapeutic use (771) 771
health aspects (752) 752
adolescent (750) 750
risk factors (692) 692
time factors (686) 686
carcinoma, renal cell - drug therapy (679) 679
prospective studies (673) 673
recombinant proteins - adverse effects (671) 671
kidney neoplasms - drug therapy (664) 664
polyethylene glycols - administration & dosage (659) 659
follow-up studies (641) 641
antineoplastic combined chemotherapy protocols - adverse effects (633) 633
infection (616) 616
plus ribavirin (611) 611
immunology (608) 608
dose-response relationship, drug (606) 606
hepatitis c, chronic - virology (599) 599
hepatitis (595) 595
medicine, general & internal (592) 592
retrospective studies (583) 583
research (570) 570
hematology (561) 561
hepacivirus - drug effects (545) 545
animals (533) 533
viral load (533) 533
hepatitis c, chronic - complications (529) 529
chronic hepatitis-c (527) 527
infectious diseases (519) 519
aged, 80 and over (494) 494
rna, viral - blood (488) 488
combination (480) 480
young adult (478) 478
combination therapy (476) 476
recurrence (472) 472
immunotherapy (471) 471
recombinant proteins - administration & dosage (470) 470
chemotherapy (463) 463
trial (462) 462
kidney neoplasms - pathology (455) 455
efficacy (450) 450
survival (446) 446
prognosis (442) 442
pegylated interferon (434) 434
double-blind (412) 412
chronic hepatitis c (408) 408
sunitinib (408) 408
combined modality therapy (405) 405
melanoma - drug therapy (396) 396
analysis (395) 395
renal cell carcinoma (389) 389
disease-free survival (377) 377
antineoplastic agents - administration & dosage (367) 367
alpha (363) 363
virology (361) 361
hepatitis c - complications (360) 360
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8908) 8908
French (202) 202
German (201) 201
Japanese (157) 157
Spanish (145) 145
Chinese (66) 66
Russian (46) 46
Polish (36) 36
Italian (26) 26
Hungarian (19) 19
Korean (14) 14
Czech (11) 11
Dutch (8) 8
Danish (7) 7
Portuguese (6) 6
Slovak (6) 6
Croatian (5) 5
Serbian (5) 5
Norwegian (4) 4
Swedish (4) 4
Turkish (4) 4
Hebrew (3) 3
Bulgarian (2) 2
Romanian (2) 2
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2012, Volume 104, Issue 2, pp. 93 - 113
With the advent of targeted agents for the treatment of renal cell carcinoma (RCC), overall survival has improved, and patients are being treated continuously... 
TYROSINE KINASE INHIBITORS | CONTROLLED-TRIAL | INTERFERON-ALPHA | SUNITINIB TREATMENT | CANCER-PATIENTS | VENOUS THROMBOEMBOLISM | ONCOLOGY | HEART-FAILURE | DOUBLE-BLIND | EXPANDED ACCESS PROGRAM | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Hypothyroidism - chemically induced | Pneumonia - therapy | Anorexia - therapy | Humans | Drug Eruptions - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Kidney Neoplasms - metabolism | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Weight Loss - drug effects | Benzenesulfonates - adverse effects | Bevacizumab | TOR Serine-Threonine Kinases - antagonists & inhibitors | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Pyrroles - adverse effects | Antineoplastic Agents - pharmacology | Carcinoma, Renal Cell - drug therapy | Everolimus | Hypothyroidism - therapy | Wound Healing - drug effects | Molecular Targeted Therapy - methods | Sirolimus - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Sirolimus - analogs & derivatives | Europe | Gastrointestinal Tract - drug effects | Cardiovascular System - drug effects | Evidence-Based Medicine | Carcinoma, Renal Cell - metabolism | Indoles - adverse effects | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Anorexia - chemically induced | Kidney Neoplasms - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Drugs | Complications and side effects | Care and treatment | Adverse and side effects | Carcinoma, Renal cell | Research | Drug therapy | Antineoplastic agents
Journal Article
Journal of Autoimmunity, ISSN 0896-8411, 2011, Volume 37, Issue 4, pp. 273 - 288
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 14, pp. 1277 - 1290
Journal Article